GB201504579D0 - Ovine vaccine - Google Patents

Ovine vaccine

Info

Publication number
GB201504579D0
GB201504579D0 GBGB1504579.2A GB201504579A GB201504579D0 GB 201504579 D0 GB201504579 D0 GB 201504579D0 GB 201504579 A GB201504579 A GB 201504579A GB 201504579 D0 GB201504579 D0 GB 201504579D0
Authority
GB
United Kingdom
Prior art keywords
ovine
vaccine
ovine vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1504579.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Moredun Research Institute
Original Assignee
Moredun Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moredun Research Institute filed Critical Moredun Research Institute
Priority to GBGB1504579.2A priority Critical patent/GB201504579D0/en
Publication of GB201504579D0 publication Critical patent/GB201504579D0/en
Priority to PCT/GB2016/050760 priority patent/WO2016147008A1/en
Priority to EP16713019.4A priority patent/EP3270956A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB1504579.2A 2015-03-18 2015-03-18 Ovine vaccine Ceased GB201504579D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1504579.2A GB201504579D0 (en) 2015-03-18 2015-03-18 Ovine vaccine
PCT/GB2016/050760 WO2016147008A1 (en) 2015-03-18 2016-03-18 Ovine vaccine
EP16713019.4A EP3270956A1 (en) 2015-03-18 2016-03-18 Ovine vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1504579.2A GB201504579D0 (en) 2015-03-18 2015-03-18 Ovine vaccine

Publications (1)

Publication Number Publication Date
GB201504579D0 true GB201504579D0 (en) 2015-05-06

Family

ID=53052002

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1504579.2A Ceased GB201504579D0 (en) 2015-03-18 2015-03-18 Ovine vaccine

Country Status (3)

Country Link
EP (1) EP3270956A1 (en)
GB (1) GB201504579D0 (en)
WO (1) WO2016147008A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111965353B (en) * 2020-08-18 2022-08-19 四川农业大学 Application of psoroptes ovis cysteine protease inhibitor and ELISA kit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113325A1 (en) * 2012-01-31 2013-08-08 Curevac Gmbh Negatively charged nucleic acid comprising complexes for immunostimulation

Also Published As

Publication number Publication date
WO2016147008A1 (en) 2016-09-22
EP3270956A1 (en) 2018-01-24

Similar Documents

Publication Publication Date Title
GB201518684D0 (en) Vaccine
PT3207053T (en) Novel immunogenic peptides
GB201502152D0 (en) Novel use
GB201410971D0 (en) Vaccine
GB201509326D0 (en) Novel use
HK1248069A1 (en) Desacetoxytubulysin h and analogs thereof
PL3185899T3 (en) Improved hvt-vectored nd-ibd vaccine
SG11201707926WA (en) Streptococcal vaccine
IL253635A0 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
GB201522132D0 (en) Vaccine
GB201616904D0 (en) Vaccine
LT3237612T (en) Sequence variants
GB201504679D0 (en) Stretcher
ZA201803039B (en) Neospora vaccine composition
GB201608821D0 (en) Vaccines
PT3188755T (en) Vaccine
GB201518940D0 (en) Novel safe
GB201504579D0 (en) Ovine vaccine
GB201417214D0 (en) Vaccine
GB201712904D0 (en) Vaccine
GB201704126D0 (en) Vaccine
GB201703809D0 (en) Vaccine
GB201603029D0 (en) Vaccine
GB201518917D0 (en) Vaccination
GB201614387D0 (en) Improved vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)